High Tide Inc. says its 51%-owned German subsidiary distributed a record 7.6 tonnes of medical marijuana during the company’s second fiscal quarter, marking another sign of rapid growth in Europe’s largest medical marijuana market. The Calgary-based company announced today that Remexian Pharma GmbH sold 7.6 tonnes of medical marijuana in Germany during the quarter ending …
Report: Congressional Research Service Says DOJ Medical Marijuana Order Could Ease 280E, Research Barriers
A new report from the Congressional Research Service says the Department of Justice’s recent order rescheduling certain medical marijuana products to Schedule III could have major implications for state-licensed medical marijuana businesses, patients, researchers and federal tax policy. The report analyzes DOJ’s April 23 final order, which moved marijuana and marijuana-derived products to Schedule III …
New Jersey Appeals Court Rules Police Officers Can’t Be Fired for Off-Duty Marijuana Use
A New Jersey appellate court has ruled that police officers cannot be fired solely for using marijuana while off duty, rejecting Jersey City’s argument that federal firearms law bars officers who consume cannabis from carrying department-issued weapons. The Superior Court of New Jersey, Appellate Division, issued the decision in Patten v. Jersey City Police Department, …
Glass House Brands Applies for DEA Registration Following Marijuana Rescheduling
Glass House Brands has applied to register certain California-licensed medical marijuana operations with the U.S. Drug Enforcement Administration (DEA), following the recent move to reschedule medical marijuana to Schedule III under the federal Controlled Substances Act. The company announced Wednesday that it submitted applications under the expedited registration pathway established by DEA as part of …
Curaleaf Reports $324 Million in Quarterly Revenue, $70 Million in Net Income
Curaleaf reported $324.2 million in revenue for the first quarter of 2026, a 6% increase from the same period last year, while also posting $70.1 million in net income from continuing operations. The company, one of the largest marijuana operators in the U.S. and international markets, said first-quarter revenue was up from $306.6 million in …
The 20 Most Popular Cannabis Strains in the United States as of May 2026
Using data from the strain review site Leafly, the research firm Headset, state regulatory commissions and recent market-tracking reports, the following list highlights 20 of the most popular cannabis strains in the United States as of May 2026. Blue Dream Blue Dream remains one of the most widely recognized and commercially resilient strains in the …
U.S. Senate Banking Committee Chair Tim Scott Says Congress Must Act on Marijuana Banking
U.S. Senator Tim Scott (R-SC), who chairs the Senate Banking, Housing, and Urban Affairs Committee, says Congress will need to act before marijuana businesses can gain reliable access to the federal banking system, even with the Trump administration moving to reschedule marijuana. Speaking Tuesday during an appearance aired by C-SPAN, Scott said federal lawmakers still …
Marijuana Policy Project Releases Pennsylvania Cannabis Voter Guide Ahead of May 19 Primary
The Marijuana Policy Project has released a Pennsylvania cannabis voter guide ahead of the state’s May 19 primary election, offering voters a district-by-district look at where legislative candidates stand on legalizing marijuana. The guide covers candidates running for the Pennsylvania House and Senate, with every House seat and half of the Senate on the ballot …
Study: Combining CBD With Ketogenic Diet May Reduce Seizures in Patients With Pharmacoresistant Epilepsy
A study published today in Epilepsy Research found that combining CBD with ketogenic diet therapy can reduce seizures in patients with pharmacoresistant epilepsy, particularly when the diet is added after CBD treatment has already begun. Researchers from The Johns Hopkins University School of Medicine conducted a retrospective chart review of 58 people with epilepsy who …
California Cannabis Sales Reach $311 Million in April, Bringing 2026 Total to $1.2 Billion
California’s legal cannabis market generated $311,089,042 in sales in April, bringing the state’s year-to-date total to roughly $1.21 billion, according to data from the research firm Headset. This resulted in around $180 million in tax revenue. The April total follows $310,443,862 in January, $277,545,874 in February and $306,342,409 in March. Combined, licensed cannabis retailers in …
Sponsored
